Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. Jan-Feb 2002;65(1):62-4.

[Preclinical Study of Noopept Toxicity]

[Article in Russian]
Affiliations
  • PMID: 12025790

[Preclinical Study of Noopept Toxicity]

[Article in Russian]
L P Kovalenko et al. Eksp Klin Farmakol. .

Abstract

Within the framework of a preclinical investigation, the new nootrope drug noopept (N-phenyl-acetyl-L-propyl-glycine ethylate) was tested for chronic toxicity upon peroral administration in a dose of 10 or 100 mg/kg over 6 months in both male and female rabbits. The results of observations showed that noopept administered in this dose range induced no irreversible pathologic changes in the organs and systems studied and exhibited no allergenic, immunotoxic, and mutagen activity. The drug affected neither the generative function nor the antenatal or postnatal progeny development. Noopept produced a dose-dependent suppression of inflammation reaction to concanavalin A and stimulated the cellular and humoral immune response in mice.

Similar articles

See all similar articles
Feedback